HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Sarter Selected Research

Cholinergic Agents (Cholinergics)

1/2022Disrupted Choline Clearance and Sustained Acetylcholine Release In Vivo by a Common Choline Transporter Coding Variant Associated with Poor Attentional Control in Humans.
1/2022Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson's disease.
1/2021Make a Left Turn: Cortico-Striatal Circuitry Mediating the Attentional Control of Complex Movements.
1/2021α4β2* Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait-Balance Disorders.
8/2019Repetitive mild concussion in subjects with a vulnerable cholinergic system: Lasting cholinergic-attentional impairments in CHT+/- mice.
6/2019Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease.
1/2019The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's disease.
1/2018Addiction vulnerability trait impacts complex movement control: Evidence from sign-trackers.
9/2017Hemicholinium-3 sensitive choline transport in human T lymphocytes: Evidence for use as a proxy for brain choline transporter (CHT) capacity.
1/2017Reducing falls in Parkinson's disease: interactions between donepezil and the 5-HT6 receptor antagonist idalopirdine on falls in a rat model of impaired cognitive control of complex movements.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Sarter Research Topics

Disease

15Schizophrenia (Dementia Praecox)
01/2016 - 05/2002
14Parkinson Disease (Parkinson's Disease)
01/2022 - 10/2013
14Cognitive Dysfunction
01/2022 - 09/2002
8Neurobehavioral Manifestations
07/2014 - 10/2007
2Movement Disorders (Movement Disorder)
01/2021 - 06/2019
2Alzheimer Disease (Alzheimer's Disease)
01/2017 - 10/2004
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2008 - 07/2007
1Brain Concussion (Cerebral Concussion)
08/2019
1Traumatic Brain Injuries (Traumatic Brain Injury)
08/2019
1Wounds and Injuries (Trauma)
08/2019
1Substance-Related Disorders (Drug Abuse)
01/2018
1Neuroinflammatory Diseases
09/2017
1Mood Disorders (Mood Disorder)
12/2013
1Brain Diseases (Brain Disorder)
11/2013
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
02/2013
1Gliosis
06/2005
1Infarction (Infarctions)
06/2005
1Ischemia
06/2005
1Embolism (Embolus)
06/2005

Drug/Important Bio-Agent (IBA)

29Cholinergic Agents (Cholinergics)IBA
01/2022 - 09/2002
4choline transporterIBA
01/2022 - 02/2013
4Pharmaceutical PreparationsIBA
01/2009 - 05/2002
3(2- (6- fluoro- 1H- indol- 3- yl)- ethyl)- (3- (2,2,3,3- tetrafluoropropoxy)benzyl)amineIBA
01/2020 - 01/2017
3Levodopa (L Dopa)FDA LinkGeneric
01/2017 - 10/2013
2Cholinergic ReceptorsIBA
01/2021 - 01/2011
2Dopamine (Intropin)FDA LinkGeneric
01/2020 - 04/2015
2Rivastigmine (Exelon)FDA LinkGeneric
01/2020 - 06/2019
2Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2017 - 01/2011
2Biomarkers (Surrogate Marker)IBA
03/2013 - 01/2012
2Clozapine (Clozaril)FDA LinkGeneric
12/2009 - 10/2008
2Amphetamine (Amfetamine)FDA LinkGeneric
10/2007 - 05/2002
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2022
1Proteins (Proteins, Gene)FDA Link
09/2017
1serotonin 6 receptorIBA
01/2017
1Donepezil (Aricept)FDA LinkGeneric
01/2017
1kynurenine-oxoglutarate transaminaseIBA
07/2014
1KynurenineIBA
07/2014
1EnzymesIBA
07/2014
1PF-04859989IBA
07/2014
1Glutamic Acid (Glutamate)FDA Link
07/2014
13- (3- (pyridine- 3- yl)- 1,2,4- oxadiazol- 5- yl)benzonitrileIBA
11/2013
1Choline (Choline Chloride)IBA
02/2013
1Cholinergic Antagonists (Anticholinergics)IBA
01/2011
1N-Methylaspartate (NMDA)IBA
12/2009
1Haloperidol (Haldol)FDA LinkGeneric
10/2008
1Antipsychotic Agents (Antipsychotics)IBA
09/2007
1Therapeutic UsesIBA
09/2007
1Neurotransmitter Agents (Neurotransmitter)IBA
07/2007
1Glial Fibrillary Acidic ProteinIBA
06/2005
1fluoro jadeIBA
06/2005
1KetamineFDA LinkGeneric
05/2002

Therapy/Procedure

1Home Nursing (Nursing, Home)
01/2020
1Therapeutics
01/2020
1Denervation
01/2017
1Long-Term Care
01/2017
1Institutionalization (Institutionalized Persons)
07/2014
1Injections
06/2005
1Microspheres (Microsphere)
06/2005